- Company Overview for EXCELYA CLINICAL RESEARCH LIMITED (13500517)
- Filing history for EXCELYA CLINICAL RESEARCH LIMITED (13500517)
- People for EXCELYA CLINICAL RESEARCH LIMITED (13500517)
- More for EXCELYA CLINICAL RESEARCH LIMITED (13500517)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
19 Mar 2024 | AA | Total exemption full accounts made up to 31 December 2022 | |
09 Nov 2023 | CS01 | Confirmation statement made on 27 October 2023 with no updates | |
02 May 2023 | AD01 | Registered office address changed from 1 Princeton Mews 167-169 London Road Kingston upon Thames Surrey KT2 6PT United Kingdom to 20-22 Venture West Greenham Business Park Newbury RG19 6HX on 2 May 2023 | |
27 Mar 2023 | CH01 | Director's details changed for Mr Frederic Paqueville on 27 March 2023 | |
06 Mar 2023 | TM01 | Termination of appointment of Alan Stuart Morgan as a director on 6 March 2023 | |
06 Mar 2023 | AP01 | Appointment of Mr Frederic Paqueville as a director on 6 March 2023 | |
27 Oct 2022 | CS01 | Confirmation statement made on 27 October 2022 with no updates | |
09 Sep 2022 | AA | Total exemption full accounts made up to 31 December 2021 | |
18 Jul 2022 | CS01 | Confirmation statement made on 27 October 2021 with no updates | |
19 Jul 2021 | AA01 | Current accounting period shortened from 31 July 2022 to 31 December 2021 | |
08 Jul 2021 | NEWINC |
Incorporation
Statement of capital on 2021-07-08
|